New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 9, 2012
08:41 EDTIPXL, AVNRAvanir sues Impax over planned Nuedexta generic, Bloomberg reports
Avanir Pharmaceuticals (AVNR) is suing Impax Laboratories (IPXL) for allegedly infringing a new patent for the drug Nuedexta and planning to market a generic version of the drug before the patent expires in 2023, reported Bloomberg, citing a complaint filed in a federal court in Delaware. Reference Link
News For AVNR;IPXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
07:10 EDTAVNRAvanir downgraded to Market Perform from Outperform at Cowen
Subscribe for More Information
December 12, 2014
11:01 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information
December 10, 2014
15:25 EDTAVNRNotable companies reporting after market close
Subscribe for More Information
December 8, 2014
11:30 EDTIPXLLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
10:20 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information
07:29 EDTIPXLUBS to hold investor trip
Subscribe for More Information
05:50 EDTAVNRStocks with implied volatility movement; AVNR MNKD
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use